REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit
Hand-out
Press Releases
THE ROSEN LAW FIRM, P. A.  
January 20, 2025

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, Jan. 20, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities

logo salamanca press

Salamanca Press

Local & Social